BCGosis
|
WikiDoc Resources for BCGosis |
|
Articles |
|---|
|
Most recent articles on BCGosis |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on BCGosis at Clinical Trials.gov Clinical Trials on BCGosis at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on BCGosis
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating BCGosis Risk calculators and risk factors for BCGosis
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for BCGosis |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
BCGosis is a rare granulomatous disease following intravesical Bacillus Calmette-Guerin immunotherapy. Intravesical administration of Bacillus Calmette-Guerin is used in the treatment of superficial transitional cell carcinoma of the urinary bladder.
On Imaging, miliary pattern of pulmonary opacification is seen.



